MacroGenics, Inc. (MGNX)
4.14
+0.01
(+0.24%)
USD |
NASDAQ |
Sep 18, 16:00
4.14
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Price to Book Value : 6.146 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 6.146 |
| September 17, 2026 | 6.131 |
| September 16, 2026 | 6.057 |
| September 15, 2026 | 5.997 |
| September 14, 2026 | 6.235 |
| September 11, 2026 | 5.938 |
| September 10, 2026 | 5.894 |
| September 09, 2026 | 6.101 |
| September 08, 2026 | 6.413 |
| September 04, 2026 | 6.532 |
| September 03, 2026 | 6.309 |
| September 02, 2026 | 6.413 |
| September 01, 2026 | 5.997 |
| August 31, 2026 | 5.923 |
| August 28, 2026 | 6.131 |
| August 27, 2026 | 6.057 |
| August 26, 2026 | 5.997 |
| August 25, 2026 | 6.190 |
| August 24, 2026 | 5.968 |
| August 21, 2026 | 6.086 |
| August 20, 2026 | 6.042 |
| August 19, 2026 | 6.190 |
| August 18, 2026 | 6.072 |
| August 17, 2026 | 6.027 |
| August 14, 2026 | 6.265 |
| Date | Value |
|---|---|
| August 13, 2026 | 6.057 |
| August 12, 2026 | 5.968 |
| August 11, 2026 | 5.819 |
| August 10, 2026 | 6.057 |
| August 07, 2026 | 5.997 |
| August 06, 2026 | 5.953 |
| August 05, 2026 | 5.790 |
| August 04, 2026 | 5.790 |
| August 03, 2026 | 5.671 |
| July 31, 2026 | 5.478 |
| July 30, 2026 | 5.612 |
| July 29, 2026 | 5.448 |
| July 28, 2026 | 5.715 |
| July 27, 2026 | 5.938 |
| July 24, 2026 | 5.493 |
| July 23, 2026 | 5.953 |
| July 22, 2026 | 6.383 |
| July 21, 2026 | 6.740 |
| July 20, 2026 | 6.413 |
| July 17, 2026 | 6.666 |
| July 16, 2026 | 6.116 |
| July 15, 2026 | 6.413 |
| July 14, 2026 | 6.369 |
| July 13, 2026 | 6.680 |
| July 10, 2026 | 6.428 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.75 |
| Xencor, Inc. | 3.651 |
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
Price to Book Value Related Metrics
| PS Ratio | 1.566 |
| Price | 4.14 |
| Earnings Yield | -5.57% |
| Market Cap | 263.49M |